Association between autophagy and inflammation in patients with rheumatoid arthritis receiving biologic therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Association between autophagy and inflammation in patients with rheumatoid arthritis receiving biologic therapy ; volume:20 ; number:1 ; day:5 ; month:12 ; year:2018 ; pages:1-11 ; date:12.2018
Arthritis Research & Therapy ; 20, Heft 1 (5.12.2018), 1-11, 12.2018
- Creator
-
Chen, Yi-Ming
Chang, Chun-Yu
Chen, Hsin-Hua
Hsieh, Chia-Wei
Tang, Kuo-Tung
Yang, Meng-Chun
Lan, Joung-Liang
Chen, Der-Yuan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-018-1763-0
- URN
-
urn:nbn:de:101:1-2019012322460755397744
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chen, Yi-Ming
- Chang, Chun-Yu
- Chen, Hsin-Hua
- Hsieh, Chia-Wei
- Tang, Kuo-Tung
- Yang, Meng-Chun
- Lan, Joung-Liang
- Chen, Der-Yuan
- SpringerLink (Online service)
Other Objects (12)
Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
Autophagy and inflammation
Experiences of mobility for people living with rheumatoid arthritis who are receiving biologic drug therapy: implications for podiatry services
Administration costs of intravenous biologic drugs for rheumatoid arthritis
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics
Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis
Safety of biologic agents after rituximab therapy in patients with rheumatoid arthritis
Vaccination in Patients with Rheumatoid Arthritis Receiving Immunotherapies
Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
Analysis of biologic therapy in rheumatoid arthritis in a southern Spanish hospital population
Discontinuation of Biologic Therapy in Rheumatoid Arthritis: Analysis from the Corrona RA Registry
Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
Autophagy and inflammation
Experiences of mobility for people living with rheumatoid arthritis who are receiving biologic drug therapy: implications for podiatry services
Administration costs of intravenous biologic drugs for rheumatoid arthritis
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics
Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis
Safety of biologic agents after rituximab therapy in patients with rheumatoid arthritis
Vaccination in Patients with Rheumatoid Arthritis Receiving Immunotherapies
Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
Analysis of biologic therapy in rheumatoid arthritis in a southern Spanish hospital population
Discontinuation of Biologic Therapy in Rheumatoid Arthritis: Analysis from the Corrona RA Registry
Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
Autophagy and inflammation
Experiences of mobility for people living with rheumatoid arthritis who are receiving biologic drug therapy: implications for podiatry services
Administration costs of intravenous biologic drugs for rheumatoid arthritis
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics
Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis
Safety of biologic agents after rituximab therapy in patients with rheumatoid arthritis
Vaccination in Patients with Rheumatoid Arthritis Receiving Immunotherapies
Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
Analysis of biologic therapy in rheumatoid arthritis in a southern Spanish hospital population